If your prostate cancer returns after radiotherapy, you may still be able to have prostate surgery in carefully selected cases. This is called salvage radical prostatectomy and aims to remove cancer that has returned within or around your prostate. However, surgery after radiotherapy is more complex because radiation can cause scarring, fibrosis and reduced flexibility in the tissues.
Your suitability depends on several factors, including your PSA pattern, MRI and PSMA PET/CT findings, biopsy results, general health and previous treatment. Current European guidance recommends salvage prostatectomy only for selected men with confirmed local recurrence, ideally in experienced specialist centres.
When Can Robotic Prostate Surgery Be Considered After Radiotherapy?
Yes, you may still be able to have robotic prostatectomy after radiotherapy, but only in carefully selected cases. Your cancer needs to have returned locally, with no evidence of nodal or distant metastatic disease on restaging, and the recurrence should be confirmed before the risks of salvage surgery are considered.
Current EAU guidance recognises salvage radical prostatectomy as a possible treatment with curative intent for selected men with biopsy-confirmed local recurrence after radiotherapy. The key word is “selected”, because a rising PSA after radiotherapy does not automatically mean that salvage surgery is the right option for you.
What Is Salvage Radical Prostatectomy?
Salvage radical prostatectomy means removing your prostate after an earlier treatment, such as radiotherapy, has not provided lasting cancer control. Because radiotherapy leaves your prostate in place, cancer can sometimes return within the gland and may still be suitable for local treatment.
However, this is not the same as having prostatectomy as your first treatment. Your surgeon is operating through tissues that have already been affected by radiotherapy, so the procedure can be more technically difficult and may carry higher risks.
Why Can Prostate Cancer Return After Radiotherapy?
Radiotherapy can be effective, but some cancer cells may survive or cancer may later recur within or beyond the treated area.
Your PSA is monitored after radiotherapy, but it does not normally fall to zero. A rising PSA therefore needs further assessment to establish where the cancer has returned.
Why Is Surgery More Difficult After Radiotherapy?
Radiotherapy can make tissues around the prostate firmer, less flexible and more fibrotic, making normal surgical planes harder to identify.
Radiation can also affect healing. Robotic technology improves visibility and precision, but it cannot reverse these tissue changes, so experience with salvage surgery remains important.
Which Parts of the Operation Can Be More Challenging?
Radiotherapy can make it harder to separate the prostate from the rectum, manage the bladder neck and reconnect the bladder to the urethra.
Scarring can also make the urinary sphincter and erectile nerves harder to preserve, contributing to higher risks of incontinence and erectile-function problems.
Does a Rising PSA Mean You Need Surgery?
No. A rising PSA needs further assessment and does not automatically mean you need salvage surgery. Biochemical recurrence is commonly defined as a PSA rise of 2 ng/mL or more above the post-treatment nadir.
Your doctors will also consider PSA doubling time, imaging and biopsy findings to establish where the cancer has returned and whether local salvage treatment may be suitable.
Tests Used Before Considering Salvage Prostatectomy
| Assessment | What it helps your team understand |
| PSA pattern | Shows whether PSA is rising and how quickly it changes over time |
| PSA doubling time | Helps assess the biological behaviour of the recurrence |
| Multiparametric MRI | Helps identify suspicious recurrence within the prostate and assess nearby tissues |
| PSMA PET/CT | Helps check whether cancer has spread to lymph nodes, bones or other areas |
| Prostate biopsy | Provides histological confirmation that cancer has returned within the prostate |
| Previous treatment details | Helps your surgeon understand how radiotherapy may have affected your tissues and anatomy |
| General health and fitness | Helps determine whether you are fit enough to benefit from major salvage surgery |
| Urinary and sexual function | Helps your team discuss likely functional effects and set realistic expectations |
Why Is a Prostate Biopsy Usually Needed?
A biopsy can be important before local salvage treatment because PSA and scans alone cannot confirm with certainty that cancer has returned within the prostate. Current EAU guidance recommends histological confirmation before local salvage treatment because these treatments can carry significant risks.
UK NICE guidance is more cautious and recommends offering prostate biopsy after radiotherapy only to people who may have local salvage therapy in the context of a clinical trial. Your specialist multidisciplinary team will therefore consider current guidance, imaging and your individual circumstances when planning further assessment.
What Role Does MRI Play Before Salvage Surgery?
Multiparametric MRI can help identify suspicious recurrence, assess nearby tissues and guide biopsy after radiotherapy.
Because treated tissue can look different on MRI, your specialist will interpret the scan alongside your PSA, biopsy results and previous treatment when considering salvage surgery.
Why Might You Need a PSMA PET/CT?
PSMA PET/CT can help show whether recurrent cancer has spread beyond the prostate. If cancer is found in lymph nodes, bones or other organs, removing the prostate alone is unlikely to control all the disease.
EAU guidance recommends PSMA PET/CT when curative salvage treatment is being considered. The scan cannot detect every microscopic cancer cell, but it can help guide the treatment plan.
Who Is Most Likely to Be Suitable for Salvage Surgery?
You may be considered for salvage surgery if biopsy confirms local recurrence and imaging shows no nodal or distant spread. Your general health and life expectancy also matter.
A lower pre-salvage PSA and less advanced original tumour stage and grade can be favourable, but these are selection factors rather than strict rules.
When Might Salvage Prostatectomy Not Be Appropriate?
Salvage prostatectomy may not be suitable if cancer has spread beyond the prostate or if major surgery would be too risky because of your general health.
- Cancer spread: Surgery may be unsuitable if cancer has spread to distant organs or lymph nodes.
- General health: Significant medical problems or frailty may make major surgery too risky.
- Urinary problems: Severe urinary symptoms after radiotherapy can affect treatment decisions.
- Cancer behaviour: Your PSA pattern and scan results help show whether local surgery is likely to provide benefit.
Severe urinary problems, cancer behaviour and previous treatment effects may also influence whether another treatment option offers a better balance of benefits and risks.
What Are the Potential Advantages of Robotic Salvage Prostatectomy?
Robotic surgery provides magnified three-dimensional vision and precise instrument control, which can help when radiotherapy has caused scarring.
A 2025 meta-analysis found lower moderate-to-severe incontinence after robotic than open salvage surgery, although serious-complication and erectile-dysfunction rates were not significantly different.
What Are the Main Risks of Surgery After Radiotherapy?
Salvage prostatectomy carries the usual risks of major prostate surgery, but some complications can be more common after radiotherapy. These can include bleeding, infection, urinary leakage, narrowing where your bladder is joined to your urethra, urinary incontinence and injury to nearby organs. Rectal injury is an important concern because radiation can make the tissues around your prostate more scarred and difficult to separate.
Your risk depends on factors such as your previous radiotherapy, anatomy, general health and the experience of your surgical team. Published studies report different complication rates, so you should use these figures as general estimates rather than a prediction of what will happen to you.
How Can Salvage Surgery Affect Urinary Continence?
Continence recovery can be less predictable after salvage prostatectomy because radiotherapy may already have affected the bladder, urethra and urinary sphincter.
Your risk also depends on your urinary function before surgery, previous treatment and surgical factors. Ask your surgeon about expected continence outcomes and available support if leakage continues.
What Happens to Erectile Function?
Erectile-function recovery can be more difficult after salvage prostatectomy than after surgery performed before radiotherapy. Radiation may already have affected the nerves and blood vessels involved in erections, while scarring can make nerve-sparing surgery more challenging.
Erectile dysfunction is common after salvage prostatectomy. The 2023 systematic review reported preserved erectile function in fewer than 16% of patients, while a 2025 meta-analysis estimated erectile dysfunction in approximately 73% at one year. Definitions and baseline erectile function varied between studies, so these figures should be used for counselling rather than as an individual prediction.
Evidence Note
An updated systematic review of 20 retrospective studies involving 4,175 men found high-grade complications in 6.6% of patients after salvage radical prostatectomy, including rectal injury in 0.9%. The same review reported preserved continence in 40.4% and erectile function in fewer than 16%, showing why functional counselling is an important part of treatment selection.
A 2025 meta-analysis found serious complications in approximately 14.6% across included salvage-prostatectomy studies and any-grade urinary incontinence in approximately 49.6% at one year. Moderate-to-severe incontinence was lower after robotic than open salvage surgery, but serious-complication and erectile-dysfunction rates were not significantly different between approaches.
Can Salvage Surgery Still Control the Cancer Long Term?
For carefully selected men, salvage prostatectomy can offer a chance of long-term cancer control when your recurrence is genuinely confined to the prostate. Published studies report encouraging long-term outcomes, although results vary because patients, previous treatments and surgical techniques differ between studies.
An updated systematic review reported 10-year metastasis-free survival ranging from approximately 72% to 77% and five-year cancer-specific survival ranging from 86.6% to 97.7% after salvage prostatectomy. However, these results came from highly selected retrospective cohorts, so your own outlook depends on factors such as PSA, Grade Group, pathological stage and whether modern restaging confirms genuinely localised recurrence.
How Does Salvage Surgery Compare With Other Treatment Options?
Salvage prostatectomy is not your only option if prostate cancer returns after radiotherapy. Depending on your individual situation, your specialist may discuss treatments such as salvage brachytherapy, stereotactic body radiotherapy, cryotherapy or high-intensity focused ultrasound. Hormone therapy or monitoring may also be considered when further local treatment is unlikely to provide enough benefit.
The EAU recommends discussing salvage prostatectomy, brachytherapy or stereotactic body radiotherapy with carefully selected patients who have biopsy-confirmed local recurrence, particularly at experienced centres. There is no single treatment that is best for everyone, so your team will consider both cancer control and the potential effects on your urinary, sexual and bowel function.
UK Guidance Note
UK and European guidance do not completely align on local salvage treatment after radiotherapy. Current NICE NG131 contains older, cautious recommendations and states that prostate biopsy after radiotherapy should only be offered to people being considered for local salvage therapy in the context of a clinical trial. NICE also emphasises that a rising PSA alone should not automatically trigger an immediate treatment change.
By contrast, current EAU 2026 guidance gives a strong recommendation to offer salvage radical prostatectomy, salvage brachytherapy or salvage stereotactic body radiotherapy to highly selected patients with biopsy-confirmed local recurrence in experienced centres. This difference is one reason recurrent prostate cancer after radiotherapy should be assessed through a specialist multidisciplinary team rather than from PSA or imaging alone.
Why Does Surgeon Experience Matter So Much?
Salvage prostatectomy is technically demanding because radiotherapy can cause scarring and make normal tissue planes harder to identify.
European guidance recommends treatment in experienced centres, so ask about your surgeon’s specific experience with salvage prostatectomy after radiotherapy.
What Should You Ask Before Considering Salvage Surgery?
Ask whether your recurrence is confined to the prostate and what your biopsy, PSA, MRI and PSMA PET/CT show.
Also discuss how salvage surgery may affect urinary and sexual function, your surgeon’s experience and alternative treatments before making a decision.
Myth vs Fact
| Myth | Fact |
| Once you have had radiotherapy, prostate surgery is impossible. | No. Salvage prostatectomy can be considered for highly selected patients with biopsy-confirmed local recurrence and no nodal or distant spread. |
| A rising PSA automatically means the cancer is still only in the prostate. | No. PSA cannot show where the recurrence is, so MRI, PSMA PET/CT and usually biopsy are needed when curative salvage treatment is being considered. |
| A positive PSMA PET scan inside the prostate means biopsy is unnecessary. | Current EAU guidance still recommends histological confirmation before local salvage treatment because of the morbidity of these procedures. |
| Robotic surgery removes the extra risks created by previous radiotherapy. | No. Robotics can improve visibility and instrument control and may reduce moderate-to-severe incontinence compared with open salvage surgery, but it does not remove radiation fibrosis, impaired healing or the overall higher risks of salvage prostatectomy. |
| Urinary and erectile recovery are the same as after first-time prostatectomy. | No. Incontinence and erectile dysfunction are substantially more common after salvage prostatectomy than after primary surgery. |
| HIFU, cryotherapy, surgery and re-irradiation all have identical evidence. | No. Current EAU guidance gives stronger recommendations for salvage prostatectomy, brachytherapy and SBRT in selected patients, while HIFU and cryotherapy remain more restricted. |
Key Takeaways
- Robotic salvage prostatectomy after radiotherapy is possible, but it is usually considered only for carefully selected patients with local recurrence.
- A rising PSA after radiotherapy does not automatically mean the cancer is still confined to the prostate or that surgery is needed.
- Biochemical recurrence after radiotherapy is commonly defined as a PSA rise of 2 ng/mL or more above the post-treatment nadir.
- MRI can help identify suspicious recurrent cancer within the prostate and guide biopsy.
- PSMA PET/CT can help determine whether recurrent cancer has spread to lymph nodes, bones or other areas before salvage treatment is considered.
- Current European guidance recommends histological confirmation with biopsy before local salvage treatment because salvage procedures carry significant risks.
- The most suitable candidates generally have localised recurrence, no nodal or distant metastases, good overall health and sufficient life expectancy to benefit from curative treatment.
- Salvage prostatectomy is more technically difficult than first-time prostate surgery because radiotherapy can cause fibrosis, scarring and reduced tissue flexibility.
- Urinary incontinence and erectile dysfunction are more common after salvage prostatectomy than after primary prostatectomy, so realistic functional expectations should be discussed before surgery.
- Robotic salvage surgery provides technical advantages and has been associated with lower moderate-to-severe urinary incontinence than open salvage surgery, although serious-complication and erectile-dysfunction rates have not clearly differed between approaches.
- Salvage prostatectomy is not the only local treatment option. Selected patients may also be considered for salvage brachytherapy or stereotactic body radiotherapy, while HIFU and cryotherapy currently have more limited evidence.
- Salvage treatment after radiotherapy should ideally be planned through an experienced specialist multidisciplinary team.
Frequently Asked Questions
1. Can you have robotic prostate surgery after radiotherapy?
Yes, you may be able to have robotic salvage prostatectomy after radiotherapy if your cancer has returned locally. Your scans, biopsy results, PSA and general health will help determine whether surgery is suitable for you.
2. What is salvage radical prostatectomy?
Salvage radical prostatectomy is surgery to remove your prostate after prostate cancer has returned following radiotherapy. It is usually considered only when tests suggest the cancer remains confined to the prostate.
3. Why is prostate surgery more difficult after radiotherapy?
Radiotherapy can cause scarring and fibrosis around your prostate, bladder and rectum. This can make the tissues less flexible and the normal surgical planes harder for your surgeon to identify.
4. Does a rising PSA mean you need salvage surgery?
No. A rising PSA after radiotherapy needs further assessment but does not automatically mean you need surgery. Biochemical recurrence is commonly defined as a PSA rise of at least 2 ng/mL above the post-treatment nadir, but MRI, PSMA PET/CT and usually biopsy are needed to determine where the cancer has returned before local salvage treatment is considered.
5. Do you need a biopsy before salvage prostatectomy?
Usually, yes. A biopsy can confirm that cancer has returned within the prostate before you undergo a major salvage operation with higher risks than first-time prostate surgery.
6. Can robotic surgery reduce the risks after radiotherapy?
Robotic surgery gives your surgeon magnified three-dimensional vision and precise instrument control. Some evidence suggests lower moderate-to-severe incontinence than with open salvage surgery, but robotics does not remove the scarring, healing problems or other risks caused by previous radiotherapy.
7. What are the risks of salvage prostate surgery?
You may have a higher risk of urinary incontinence, erectile dysfunction, bleeding, urinary leakage and bladder-neck problems after radiotherapy. There is also a risk of injury to nearby structures, including the rectum.
8. Can you regain urinary control after salvage prostatectomy?
You can regain urinary control, but recovery may be slower and less predictable after radiotherapy. Your pre-existing urinary function, previous treatment and surgical technique can all affect your recovery.
9. Can you still have nerve-sparing surgery after radiotherapy?
Nerve sparing may be possible in selected cases, but radiotherapy can make the tissues around the nerves more scarred. Your surgeon will prioritise cancer removal when deciding whether the nerves can be safely preserved.
10. What should you ask before considering salvage surgery?
Ask whether your recurrence is confined to the prostate, whether you need a biopsy and what your MRI and PSMA PET/CT show. You should also discuss your surgeon’s experience, potential urinary and sexual side effects and alternative treatments.
Final Thoughts: Making an Informed Decision About Salvage Surgery
If your prostate cancer returns after radiotherapy, robotic salvage prostatectomy may be an option in carefully selected cases. However, surgery in previously irradiated tissues is more complex and can carry higher risks, particularly for urinary continence and erectile function. Your PSA, biopsy, MRI, PSMA PET/CT, general health and previous treatment all need to be considered before deciding whether surgery is appropriate for you.
If you are considering robotic prostate surgery in London, choosing a surgeon and centre with specific experience in salvage prostatectomy can be particularly important. You can contact our team to discuss your individual circumstances, understand your treatment options and arrange a consultation tailored to your needs.
References:
- National Institute for Health and Care Excellence (2019, updated 2021) Prostate cancer: diagnosis and management. NICE guideline NG131. Available at: https://www.nice.org.uk/guidance/ng131
- European Association of Urology (2026) EAU Guidelines on Prostate Cancer. EAU Guidelines Office, Arnhem, The Netherlands. Available at: https://uroweb.org/guidelines/prostate-cancer
- Marra, G. et al. (2023) ‘Salvage Radical Prostatectomy for Recurrent Prostate Cancer After Primary Nonsurgical Treatment: An Updated Systematic Review’, European Urology Focus, 9(2), pp. 251–257. Available at: https://pubmed.ncbi.nlm.nih.gov/36822924/
- Zhou, Y. et al. (2025) ‘Functional outcomes and complications following salvage radical prostatectomy for post radiotherapy recurrent prostate cancer: A meta-analysis’, Medicine, 104(39), e44440. Available at: https://pubmed.ncbi.nlm.nih.gov/41029069/
- Valle, L.F. et al. (2021) ‘A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)’, European Urology, 80(3), pp. 280–292. Available at: https://pubmed.ncbi.nlm.nih.gov/33309278/
- Roach, M. et al. (2006) ‘Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference’, International Journal of Radiation Oncology, Biology, Physics, 65(4), pp. 965–974. Available at: https://pubmed.ncbi.nlm.nih.gov/16798415/